Following the acquisition of ORPEGEN Peptide Chemicals GmbH
on January 1, 2015, CordenPharma International announces that on July 1,2015, the non-GMP facility and personnel moved to a location in Frankfurt-Fechenheim now called CordenPharma Frankfurt.
Over the past year, the facility has worked on a number of projects with all CordenPharma peptide sites including CordenPharma Switzerland
, CordenPharma Colorado
and CordenPharma Peptisyntha
. The group is comprised of 10 peptide chemists with a focus on non-GMP research and development and is now an integral part of the CordenPharma Peptides / Lipids / Carbohydrates platform.
Contact Us to place an inquiry for non-GMP Peptides.